 | • レポートコード：GIR-105X12827 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍分子診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍分子診断の種類別市場規模（PCR、マルチプレックスPCR、In Situハイブリダイゼーション、等温核酸増幅技術（INAAT））、用途別市場規模（乳がん、前立腺がん、結腸直腸がん、子宮頸がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍分子診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Bayer Healthcare、Becton Dickinson、Cepheid、Dako、Danaher Corporation、Gen Probe(Hologic)、Roche Diagnostics、Siemens Healthcare ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：PCR、マルチプレックスPCR、In Situハイブリダイゼーション、等温核酸増幅技術（INAAT） ・用途別分析2016年-2026年：乳がん、前立腺がん、結腸直腸がん、子宮頸がん、その他 ・腫瘍分子診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍分子診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍分子診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍分子診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍分子診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology Based Molecular Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology Based Molecular Diagnostics size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oncology Based Molecular Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oncology Based Molecular Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PCR
Multiplex PCR
In Situ Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Market segment by Application can be divided into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Other
The key market players for global Oncology Based Molecular Diagnostics market are listed below:
Abbott Laboratories
Bayer Healthcare
Becton Dickinson
Cepheid
Dako
Danaher Corporation
Gen Probe(Hologic)
Roche Diagnostics
Siemens Healthcare
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oncology Based Molecular Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Based Molecular Diagnostics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 PCR
1.2.3 Multiplex PCR
1.2.4 In Situ Hybridization
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Based Molecular Diagnostics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Other
1.4 Global Oncology Based Molecular Diagnostics Market Size & Forecast
1.4.1 Global Oncology Based Molecular Diagnostics Sales in Value (2016-2026))
1.4.2 Global Oncology Based Molecular Diagnostics Sales in Volume (2016-2026)
1.4.3 Global Oncology Based Molecular Diagnostics Price by Type (2016-2026) & (USD/Unit)
1.5 Global Oncology Based Molecular Diagnostics Production Capacity Analysis
1.5.1 Global Oncology Based Molecular Diagnostics Total Production Capacity (2016-2026)
1.5.2 Global Oncology Based Molecular Diagnostics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Based Molecular Diagnostics Market Drivers
1.6.2 Oncology Based Molecular Diagnostics Market Restraints
1.6.3 Oncology Based Molecular Diagnostics Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Product and Services
2.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bayer Healthcare
2.2.1 Bayer Healthcare Details
2.2.2 Bayer Healthcare Major Business
2.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Product and Services
2.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Product and Services
2.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Cepheid
2.4.1 Cepheid Details
2.4.2 Cepheid Major Business
2.4.3 Cepheid Oncology Based Molecular Diagnostics Product and Services
2.4.4 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dako
2.5.1 Dako Details
2.5.2 Dako Major Business
2.5.3 Dako Oncology Based Molecular Diagnostics Product and Services
2.5.4 Dako Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Product and Services
2.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Gen Probe(Hologic)
2.7.1 Gen Probe(Hologic) Details
2.7.2 Gen Probe(Hologic) Major Business
2.7.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Services
2.7.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Roche Diagnostics
2.8.1 Roche Diagnostics Details
2.8.2 Roche Diagnostics Major Business
2.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Product and Services
2.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Siemens Healthcare
2.9.1 Siemens Healthcare Details
2.9.2 Siemens Healthcare Major Business
2.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Product and Services
2.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oncology Based Molecular Diagnostics Sales by Manufacturer
3.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oncology Based Molecular Diagnostics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oncology Based Molecular Diagnostics
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Based Molecular Diagnostics Manufacturer Market Share
3.4.2 Top 6 Oncology Based Molecular Diagnostics Manufacturer Market Share
3.5 Global Oncology Based Molecular Diagnostics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oncology Based Molecular Diagnostics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Based Molecular Diagnostics Market Size by Region
4.1.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Region (2016-2026)
4.1.2 Global Oncology Based Molecular Diagnostics Revenue by Region (2016-2026)
4.2 North America Oncology Based Molecular Diagnostics Revenue (2016-2026)
4.3 Europe Oncology Based Molecular Diagnostics Revenue (2016-2026)
4.4 Asia-Pacific Oncology Based Molecular Diagnostics Revenue (2016-2026)
4.5 South America Oncology Based Molecular Diagnostics Revenue (2016-2026)
4.6 Middle East and Africa Oncology Based Molecular Diagnostics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Type (2016-2026)
5.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2016-2026)
5.3 Global Oncology Based Molecular Diagnostics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oncology Based Molecular Diagnostics Sales in Volume by Application (2016-2026)
6.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2016-2026)
6.3 Global Oncology Based Molecular Diagnostics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Based Molecular Diagnostics Sales by Type (2016-2026)
7.2 North America Oncology Based Molecular Diagnostics Sales by Application (2016-2026)
7.3 North America Oncology Based Molecular Diagnostics Market Size by Country
7.3.1 North America Oncology Based Molecular Diagnostics Sales in Volume by Country (2016-2026)
7.3.2 North America Oncology Based Molecular Diagnostics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Based Molecular Diagnostics Sales by Type (2016-2026)
8.2 Europe Oncology Based Molecular Diagnostics Sales by Application (2016-2026)
8.3 Europe Oncology Based Molecular Diagnostics Market Size by Country
8.3.1 Europe Oncology Based Molecular Diagnostics Sales in Volume by Country (2016-2026)
8.3.2 Europe Oncology Based Molecular Diagnostics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2016-2026)
9.2 Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2016-2026)
9.3 Asia-Pacific Oncology Based Molecular Diagnostics Market Size by Region
9.3.1 Asia-Pacific Oncology Based Molecular Diagnostics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oncology Based Molecular Diagnostics Sales by Type (2016-2026)
10.2 South America Oncology Based Molecular Diagnostics Sales by Application (2016-2026)
10.3 South America Oncology Based Molecular Diagnostics Market Size by Country
10.3.1 South America Oncology Based Molecular Diagnostics Sales in Volume by Country (2016-2026)
10.3.2 South America Oncology Based Molecular Diagnostics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2016-2026)
11.2 Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2016-2026)
11.3 Middle East & Africa Oncology Based Molecular Diagnostics Market Size by Country
11.3.1 Middle East & Africa Oncology Based Molecular Diagnostics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oncology Based Molecular Diagnostics Typical Distributors
12.3 Oncology Based Molecular Diagnostics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oncology Based Molecular Diagnostics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oncology Based Molecular Diagnostics Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Oncology Based Molecular Diagnostics Product and Services
Table 6. Abbott Laboratories Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Healthcare Major Business
Table 9. Bayer Healthcare Oncology Based Molecular Diagnostics Product and Services
Table 10. Bayer Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 12. Becton Dickinson Major Business
Table 13. Becton Dickinson Oncology Based Molecular Diagnostics Product and Services
Table 14. Becton Dickinson Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cepheid Basic Information, Manufacturing Base and Competitors
Table 16. Cepheid Major Business
Table 17. Cepheid Oncology Based Molecular Diagnostics Product and Services
Table 18. Cepheid Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dako Basic Information, Manufacturing Base and Competitors
Table 20. Dako Major Business
Table 21. Dako Oncology Based Molecular Diagnostics Product and Services
Table 22. Dako Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Corporation Major Business
Table 25. Danaher Corporation Oncology Based Molecular Diagnostics Product and Services
Table 26. Danaher Corporation Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gen Probe(Hologic) Basic Information, Manufacturing Base and Competitors
Table 28. Gen Probe(Hologic) Major Business
Table 29. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Services
Table 30. Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 32. Roche Diagnostics Major Business
Table 33. Roche Diagnostics Oncology Based Molecular Diagnostics Product and Services
Table 34. Roche Diagnostics Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 36. Siemens Healthcare Major Business
Table 37. Siemens Healthcare Oncology Based Molecular Diagnostics Product and Services
Table 38. Siemens Healthcare Oncology Based Molecular Diagnostics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Oncology Based Molecular Diagnostics Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Oncology Based Molecular Diagnostics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Oncology Based Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Oncology Based Molecular Diagnostics Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oncology Based Molecular Diagnostics Production Site of Key Manufacturer
Table 44. Global Oncology Based Molecular Diagnostics Sales by Region (2016-2021e) & (K Units)
Table 45. Global Oncology Based Molecular Diagnostics Sales by Region (2021-2026) & (K Units)
Table 46. Global Oncology Based Molecular Diagnostics Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Oncology Based Molecular Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 49. Global Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 50. Global Oncology Based Molecular Diagnostics Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Oncology Based Molecular Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Oncology Based Molecular Diagnostics Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Oncology Based Molecular Diagnostics Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 55. Global Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 56. Global Oncology Based Molecular Diagnostics Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Oncology Based Molecular Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Oncology Based Molecular Diagnostics Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Oncology Based Molecular Diagnostics Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Oncology Based Molecular Diagnostics Sales by Country (2016-2021e) & (K Units)
Table 61. North America Oncology Based Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 62. North America Oncology Based Molecular Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Oncology Based Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 65. North America Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 66. North America Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 67. North America Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 68. Europe Oncology Based Molecular Diagnostics Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Oncology Based Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 70. Europe Oncology Based Molecular Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Oncology Based Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 74. Europe Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Oncology Based Molecular Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 84. South America Oncology Based Molecular Diagnostics Sales by Country (2016-2021e) & (K Units)
Table 85. South America Oncology Based Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 86. South America Oncology Based Molecular Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Oncology Based Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 89. South America Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 90. South America Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 91. South America Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Oncology Based Molecular Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Oncology Based Molecular Diagnostics Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Oncology Based Molecular Diagnostics Typical Distributors
Table 103. Oncology Based Molecular Diagnostics Typical Customers
List of Figures
Figure 1. Oncology Based Molecular Diagnostics Picture
Figure 2. Global Oncology Based Molecular Diagnostics Sales Market Share by Type in 2020
Figure 3. PCR
Figure 4. Multiplex PCR
Figure 5. In Situ Hybridization
Figure 6. Isothermal Nucleic Acid Amplification Technology (INAAT)
Figure 7. Global Oncology Based Molecular Diagnostics Sales Market Share by Application in 2020
Figure 8. Breast Cancer
Figure 9. Prostate Cancer
Figure 10. Colorectal Cancer
Figure 11. Cervical Cancer
Figure 12. Other
Figure 13. Global Oncology Based Molecular Diagnostics Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Oncology Based Molecular Diagnostics Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Oncology Based Molecular Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Oncology Based Molecular Diagnostics Sales (2016-2026) & (K Units)
Figure 35. Global Oncology Based Molecular Diagnostics Production Capacity (2016-2026) & (K Units)
Figure 36. Global Oncology Based Molecular Diagnostics Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Oncology Based Molecular Diagnostics Market Drivers
Figure 38. Oncology Based Molecular Diagnostics Market Restraints
Figure 39. Oncology Based Molecular Diagnostics Market Trends
Figure 40. Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturer in 2020
Figure 41. Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturer in 2020
Figure 42. Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Oncology Based Molecular Diagnostics Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Oncology Based Molecular Diagnostics Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Oncology Based Molecular Diagnostics Sales Market Share by Region (2016-2026)
Figure 46. Global Oncology Based Molecular Diagnostics Revenue Market Share by Region (2016-2026)
Figure 47. North America Oncology Based Molecular Diagnostics Revenue (2016-2026) & (USD Million)
Figure 48. Europe Oncology Based Molecular Diagnostics Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Oncology Based Molecular Diagnostics Revenue (2016-2026) & (USD Million)
Figure 50. South America Oncology Based Molecular Diagnostics Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Oncology Based Molecular Diagnostics Revenue (2016-2026) & (USD Million)
Figure 52. Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2016-2026)
Figure 54. Global Oncology Based Molecular Diagnostics Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 56. Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2016-2026)
Figure 57. Global Oncology Based Molecular Diagnostics Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Oncology Based Molecular Diagnostics Sales Market Share by Country (2016-2026)
Figure 59. North America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2016-2026)
Figure 60. North America Oncology Based Molecular Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. North America Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. Europe Oncology Based Molecular Diagnostics Sales Market Share by Country (2016-2026)
Figure 63. Europe Oncology Based Molecular Diagnostics Revenue Market Share by Country (2016-2026)
Figure 64. Europe Oncology Based Molecular Diagnostics Sales Market Share by Type (2016-2026)
Figure 65. Europe Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Oncology Based Molecular Diagnostics Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 70. South America Oncology Based Molecular Diagnostics Sales Market Share by Country (2016-2026)
Figure 71. South America Oncology Based Molecular Diagnostics Revenue Market Share by Country (2016-2026)
Figure 72. South America Oncology Based Molecular Diagnostics Sales Market Share by Type (2016-2026)
Figure 73. South America Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Oncology Based Molecular Diagnostics Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Oncology Based Molecular Diagnostics Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
腫瘍学分子診断の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen t…- 分子診断の世界市場2018-2025 Molecular diagnosis refers to the use of molecular biological methods to detect changes in the structure or expression levels of genetic materials in patients to make a diagnosis.Asia Pacific is expected to register the highest CAGR in the global molecular diagnostics market during the forecast peri…
- 分子クラミジアトラコマチス（CT）/ナイセリア淋病（NG）診断機器の世界市場2018-2025 Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Causal organism for infectious diseases could be bacteria, viruses, parasites or fungi and can be spread, directly or indirectly, from one person to another. Mole…
- 獣医学分子診断の世界市場2018-2025 The molecular diagnostic is defined as a technique for used in the laboratory for to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals.Rising prevalence of various animal diseases globally is expected to favor the veterinary molecular …
- ウイルス分子診断の世界市場2018-2025 Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastruc…